Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 18, 2023 08:00 ET | Source: Kaléo

U.S. Department of Defense Selects Kaléo to Develop Next Generation Nerve Agent Countermeasure

Richmond, Virginia, July 18, 2023 (GLOBE NEWSWIRE) -- Kaléo, a privately-held U.S. pharmaceutical company, today announced their selection by the U.S. Department of Defense (DOD) Joint Program...